top of page

192nd Bi-monthly Scientific Meeting - 16th May 2013

  • May 16, 2013
  • 1 min read
Presentations

Anticholestatic effects of bezafibrate in patients with primary biliary cirhrosis treated with UDCA

Dr Wing-I Cheung (Our Lady of Maryknoll Hospital, Hong Kong)

Related Posts

See All

© 2023  by  The Hong Kong Association for the Study of Liver Diseases (Dr. James Fung).  Designed by Dennis Cheung @ wixexpert.hk.

bottom of page